Annexon (ANNX) News Today → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free ANNX Stock Alerts $4.36 -0.14 (-3.11%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 4:05 PM | globenewswire.comAnnexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)May 16 at 8:38 AM | marketbeat.comFY2024 EPS Estimates for Annexon, Inc. (NASDAQ:ANNX) Lifted by Cantor FitzgeraldAnnexon, Inc. (NASDAQ:ANNX - Free Report) - Cantor Fitzgerald raised their FY2024 earnings estimates for Annexon in a research note issued on Tuesday, May 14th. Cantor Fitzgerald analyst P. Stavropoulos now anticipates that the company will post earnings per share of ($0.88) for the year, up fromMay 16 at 3:44 AM | americanbankingnews.comFY2028 Earnings Forecast for Annexon, Inc. Issued By HC Wainwright (NASDAQ:ANNX)May 15 at 3:32 PM | marketbeat.comAnnexon (NASDAQ:ANNX) Price Target Cut to $10.00Wells Fargo & Company lowered their price objective on shares of Annexon from $12.00 to $10.00 and set an "overweight" rating for the company in a research note on Wednesday.May 15 at 9:34 AM | marketbeat.comFY2028 EPS Estimates for Annexon, Inc. Cut by Analyst (NASDAQ:ANNX)Annexon, Inc. (NASDAQ:ANNX - Free Report) - Equities research analysts at HC Wainwright reduced their FY2028 earnings per share (EPS) estimates for Annexon in a research note issued to investors on Tuesday, May 14th. HC Wainwright analyst A. Fein now anticipates that the company will earn $1.14 pMay 15 at 6:22 AM | americanbankingnews.comAnnexon (NASDAQ:ANNX) Rating Reiterated by HC WainwrightMay 15 at 2:24 AM | americanbankingnews.comAnnexon (NASDAQ:ANNX) Receives "Buy" Rating from Needham & Company LLCMay 14 at 12:34 PM | markets.businessinsider.comBuy Rating on Annexon Biosciences Backed by Efficacious ANX007 Data and Meticulous Phase 3 Trial DesignMay 14 at 7:33 AM | finance.yahoo.comWe Think Annexon (NASDAQ:ANNX) Can Afford To Drive Business GrowthMay 13 at 11:43 AM | marketbeat.comNeedham & Company LLC Reiterates Buy Rating for Annexon (NASDAQ:ANNX)Needham & Company LLC restated a "buy" rating and set a $16.00 price objective on shares of Annexon in a research report on Monday.May 13 at 8:00 AM | globenewswire.comAnnexon Reports First Quarter 2024 Financial Results and Key Anticipated MilestonesMay 12, 2024 | americanbankingnews.comAnnexon, Inc. (NASDAQ:ANNX) Sees Large Growth in Short InterestMay 9, 2024 | globenewswire.comAnnexon Biosciences to Present at the Bank of America Health Care ConferenceMay 7, 2024 | globenewswire.comAnnexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual MeetingMay 1, 2024 | globenewswire.comAnnexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual MeetingApril 29, 2024 | marketbeat.comShort Interest in Annexon, Inc. (NASDAQ:ANNX) Grows By 15.3%Annexon, Inc. (NASDAQ:ANNX - Get Free Report) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 4,140,000 shares, a growth of 15.3% from the March 31st total of 3,590,000 shares. Based on an average trading volume of 1,600,000 shares, the short-interest ratio is presently 2.6 days.April 24, 2024 | marketbeat.comCantor Fitzgerald Reaffirms "Overweight" Rating for Annexon (NASDAQ:ANNX)Cantor Fitzgerald reaffirmed an "overweight" rating on shares of Annexon in a research note on Wednesday.April 20, 2024 | morningstar.comAnnexon Inc Ordinary SharesApril 19, 2024 | marketbeat.comVontobel Holding Ltd. Decreases Stock Position in Annexon, Inc. (NASDAQ:ANNX)Vontobel Holding Ltd. cut its holdings in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 27.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 650,911 shares of the company's stock after selling 247,874 shaApril 17, 2024 | finance.yahoo.comAre Medical Stocks Lagging Annexon (ANNX) This Year?April 17, 2024 | finance.yahoo.comAre Medical Stocks Lagging Annexon (ANNX) This Year?April 16, 2024 | globenewswire.comAnnexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)April 16, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Shares Gap Down to $5.74Annexon (NASDAQ:ANNX) Shares Gap Down to $5.74April 15, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Trading Down 3.5%Annexon (NASDAQ:ANNX) Shares Down 3.5%April 12, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Short Interest UpdateAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 3,590,000 shares, a growth of 44.2% from the March 15th total of 2,490,000 shares. Based on an average trading volume of 1,570,000 shares, the days-to-cover ratio is currently 2.3 days.April 11, 2024 | markets.businessinsider.comBuy Rating on Annexon Biosciences: Promising Pipeline and Strategic Growth PotentialApril 11, 2024 | insidertrades.comInsider Buying: Annexon, Inc. (NASDAQ:ANNX) Director Buys 3,200 Shares of StockApril 10, 2024 | marketbeat.comInsider Buying: Annexon, Inc. (NASDAQ:ANNX) Director Purchases 3,200 Shares of StockAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) Director William H. Carson bought 3,200 shares of the company's stock in a transaction on Monday, April 8th. The shares were purchased at an average cost of $6.07 per share, for a total transaction of $19,424.00. Following the transaction, the director now owns 3,200 shares in the company, valued at $19,424. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.April 9, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Shares Gap Down to $6.05Annexon (NASDAQ:ANNX) Shares Gap Down to $6.05April 8, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Shares Down 4.5% Annexon (NASDAQ:ANNX) Trading Down 4.5%April 3, 2024 | marketbeat.comAnnexon's (ANNX) "Overweight" Rating Reaffirmed at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating on shares of Annexon in a research note on Wednesday.April 3, 2024 | globenewswire.comAnnexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare ConferenceApril 1, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Annexon Biosciences (ANNX), Insmed (INSM)April 1, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) PT Raised to $13.00 at JPMorgan Chase & Co.JPMorgan Chase & Co. upped their price objective on shares of Annexon from $11.00 to $13.00 and gave the stock an "overweight" rating in a research note on Monday.March 29, 2024 | marketbeat.comFY2024 EPS Estimates for Annexon, Inc. Lifted by HC Wainwright (NASDAQ:ANNX)Annexon, Inc. (NASDAQ:ANNX - Free Report) - Investment analysts at HC Wainwright raised their FY2024 earnings per share estimates for Annexon in a report released on Wednesday, March 27th. HC Wainwright analyst A. Fein now expects that the company will post earnings of ($1.50) per share for the yMarch 28, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Price Target Raised to $10.00 at Bank of AmericaBank of America lifted their target price on shares of Annexon from $7.00 to $10.00 and gave the company a "buy" rating in a research note on Thursday.March 28, 2024 | markets.businessinsider.comAnticipating Growth: Positive Outlook for Annexon Biosciences Amid Upcoming Clinical Trials and New Data ReadoutsMarch 28, 2024 | marketbeat.comHC Wainwright Comments on Annexon, Inc.'s Q1 2024 Earnings (NASDAQ:ANNX)Annexon, Inc. (NASDAQ:ANNX - Free Report) - Equities researchers at HC Wainwright issued their Q1 2024 earnings per share estimates for shares of Annexon in a report released on Wednesday, March 27th. HC Wainwright analyst A. Fein expects that the company will earn ($0.35) per share for the quartMarch 27, 2024 | finanznachrichten.deAnnexon Biosciences: Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated MilestonesMarch 27, 2024 | markets.businessinsider.comAnnexon Biosciences (ANNX) Receives a Buy from TD CowenMarch 27, 2024 | marketbeat.comWells Fargo & Company Raises Annexon (NASDAQ:ANNX) Price Target to $12.00Wells Fargo & Company lifted their price target on shares of Annexon from $11.00 to $12.00 and gave the company an "overweight" rating in a research note on Wednesday.March 27, 2024 | marketbeat.comAnnexon's (ANNX) "Buy" Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and issued a $30.00 price objective on shares of Annexon in a research report on Wednesday.March 26, 2024 | globenewswire.comAnnexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated MilestonesMarch 18, 2024 | globenewswire.comAnnexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)March 16, 2024 | ca.finance.yahoo.comANNX Jul 2024 7.500 putMarch 16, 2024 | ca.finance.yahoo.comANNX Apr 2024 2.500 callMarch 16, 2024 | finance.yahoo.comANNX Apr 2024 7.500 putMarch 16, 2024 | finance.yahoo.comNational group to cut realtor commissions, make home-buying more affordableMarch 15, 2024 | finance.yahoo.comCannabis Grower Ascend Seeks Private Loan to Refinance DebtMarch 13, 2024 | seekingalpha.comHRTX, LUNA and ARQ among mid-day movers Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. ANNX Media Mentions By Week ANNX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANNX News Sentiment▼0.460.55▲Average Medical News Sentiment ANNX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANNX Articles This Week▼222▲ANNX Articles Average Week Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BMEA News Today HRTX News Today KRRO News Today MRSN News Today LXRX News Today NGNE News Today CRBP News Today ESPR News Today PEPG News Today RVNC News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANNX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe 1,000X Crypto PlaybookTrue Market InsidersGold Set to EXPLODE!Gold Safe ExchangeCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMost important medical advance in 100 yearsThe Oxford ClubBill Clinton Backing Biden Replacement???The Freeport SocietyCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annexon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
